Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Commun (Camb) ; 54(38): 4743-4760, 2018 May 08.
Article in English | MEDLINE | ID: mdl-29696286

ABSTRACT

This feature article provides a personal insight into the research from my group over the past 10 years. In particular, the article explains how, inspired in 2005 by meeting my now-husband, Sam, who had cystic fibrosis, and who in 2011 went on to have a double lung transplant, I took an active decision to follow a more applied approach to some of our research, attempting to use fundamental supramolecular chemistry to address problems of medical interest. In particular, our strategy uses self-assembly to fabricate biologically-active nanosystems from simple low-molecular-weight building blocks. These systems can bind biological polyanions in highly competitive conditions, allowing us to approach applications in gene delivery and coagulation control. In the process, however, we have also developed new fundamental principles such as self-assembled multivalency (SAMul), temporary 'on-off' multivalency, and adaptive/shape-persistent multivalent binding. By targeting materials with applications in drug formulation and tissue engineering, we have discovered novel self-assembling low-molecular-weight hydrogelators based on the industrially-relevant dibenzylidenesorbitol framework and developed innovative approaches to spatially-resolved gels and functional multicomponent hybrid hydrogels. In this way, taking an application-led approach to research has also delivered significant academic value and conceptual advances. Furthermore, beginning to translate fundamental supramolecular chemistry into real-world applications, starts to demonstrate the power of this approach, and its potential to transform the world around us for the better.


Subject(s)
DNA/chemistry , Dendrimers/pharmacology , Drug Carriers/pharmacology , Nanostructures/chemistry , Animals , Dendrimers/chemistry , Dendrimers/history , Drug Carriers/chemistry , Drug Carriers/history , Gene Transfer Techniques , History, 21st Century , Humans , Hydrogels/chemistry , Hydrogels/history , Hydrogels/pharmacology , Nanostructures/history , United Kingdom
3.
J Control Release ; 190: 254-73, 2014 Sep 28.
Article in English | MEDLINE | ID: mdl-24746623

ABSTRACT

Over the past decades, significant progress has been made in the field of hydrogels as functional biomaterials. Biomedical application of hydrogels was initially hindered by the toxicity of crosslinking agents and limitations of hydrogel formation under physiological conditions. Emerging knowledge in polymer chemistry and increased understanding of biological processes resulted in the design of versatile materials and minimally invasive therapies. Hydrogel matrices comprise a wide range of natural and synthetic polymers held together by a variety of physical or chemical crosslinks. With their capacity to embed pharmaceutical agents in their hydrophilic crosslinked network, hydrogels form promising materials for controlled drug release and tissue engineering. Despite all their beneficial properties, there are still several challenges to overcome for clinical translation. In this review, we provide a historical overview of the developments in hydrogel research from simple networks to smart materials.


Subject(s)
Delayed-Action Preparations , Drug Carriers , Hydrogels , Biocompatible Materials/history , Delayed-Action Preparations/history , Drug Carriers/chemistry , Drug Carriers/history , History, 20th Century , History, 21st Century , Humans , Hydrogels/chemistry , Hydrogels/history , Polyethylene Glycols , Polyhydroxyethyl Methacrylate
SELECTION OF CITATIONS
SEARCH DETAIL
...